Valuation: Enovis Corporation

Market Cap 146.9Cr 128.85Cr 118.95Cr 109.92Cr 208.35Cr 14TCr 212.52Cr 1.43TCr 555.63Cr 6.88TCr 551.65Cr 539.56Cr 24TCr P/E 2026 *
210x
P/E 2027 * 26.4x
Enterprise Value 266.63Cr 233.86Cr 215.91Cr 199.52Cr 378.17Cr 26TCr 385.74Cr 2.6TCr 1.01TCr 12TCr 1TCr 979.35Cr 43TCr EV / Sales 2026 *
1.14x
EV / Sales 2027 * 1.03x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day-7.25%
1 week+18.11%
Current month+14.35%
1 month-0.04%
3 months-0.50%
6 months-17.90%
Current year-11.15%
1 week 20.23
Extreme 20.23
26.5
1 month 19.14
Extreme 19.14
26.5
Current year 19.14
Extreme 19.14
29.89
1 year 19.14
Extreme 19.14
36.82
3 years 19.14
Extreme 19.14
66.14
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/06Free

Director

846 0.0015%
15/06Buy

Chief Administrative Officer

1,000 0.0017%
11/06Free

Chief Administrative Officer

1,000 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-7.68%+18.11%-31.87%-63.23% 146.9Cr
+0.70%+4.33%-16.05%+10.72% 13TCr
-1.36%+2.88%+2.36%-3.80% 1.29TCr
-2.30%+11.14%+49.27%+116.11% 884.4Cr
-0.46%-0.37%-49.18%-73.25% 387.17Cr
-1.81%+3.71%+20.09%+40.77% 265.47Cr
-1.60%-2.24%-12.94%-19.85% 179.73Cr
-1.01%+1.33%-2.43%-25.57% 161.37Cr
-2.04%+8.25%-63.12%-84.17% 144.3Cr
Average -1.63%+4.96%-11.54%-11.36% 1.79TCr
Weighted average by Cap. -0.85%+4.71%-11.59%+11.60%

Financials

2026 *2027 *
Net sales 234.47Cr 205.65Cr 189.86Cr 175.45Cr 332.54Cr 22TCr 339.2Cr 2.28TCr 886.84Cr 11TCr 880.49Cr 861.19Cr 38TCr 246.65Cr 216.34Cr 199.73Cr 184.57Cr 349.83Cr 24TCr 356.83Cr 2.4TCr 932.95Cr 12TCr 926.26Cr 905.96Cr 40TCr
Net income 29.6L 25.96L 23.97L 22.15L 41.98L 28Cr 42.82L 2.88Cr 1.12Cr 14Cr 1.11Cr 1.09Cr 48Cr 5.42Cr 4.76Cr 4.39Cr 4.06Cr 7.69Cr 519.17Cr 7.84Cr 53Cr 21Cr 254.06Cr 20Cr 20Cr 881.95Cr
Net Debt 119.73Cr 105.02Cr 97Cr 90Cr 169.82Cr 11TCr 173.22Cr 1.17TCr 452.88Cr 5.61TCr 449.64Cr 439.78Cr 19TCr 106.59Cr 93Cr 86Cr 80Cr 151.18Cr 10TCr 154.21Cr 1.04TCr 403.17Cr 4.99TCr 400.28Cr 391.51Cr 17TCr
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
09/26/09 $23.56 -7.68% 8,89,916
07/26/07 $25.52 -1.47% 9,89,227
06/26/06 $25.90 +15.11% 21,55,004
02/26/02 $22.50 +12.28% 13,02,522
01/26/01 $20.04 -3.19% 15,02,881
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
25.52USD
Average target price
41.90USD
Spread / Average Target
+64.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock